Dimension Therapeutics Inc buy melinda
Start price
27.01.17
/
50%
€4.15
Target price
10.03.17
€9.02
Performance (%)
-57.61%
End price
10.03.17
€1.76
Summary
This prediction ended on 10.03.17 with a price of €1.76. Massive losses of -57.61% were the result for the BUY prediction by melinda. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Dimension Therapeutics Inc | - | - | - | - |
| iShares Core DAX® | 1.717% | 3.368% | 5.887% | 52.377% |
| iShares Nasdaq 100 | -4.565% | -4.238% | 21.386% | 72.449% |
| iShares Nikkei 225® | -7.120% | -11.869% | 42.357% | 57.579% |
| iShares S&P 500 | -0.894% | 1.687% | 19.495% | 62.154% |
Comments by melinda for this prediction
In the thread Dimension Therapeutics Inc diskutieren
Hämophilie
Phase 1 der 31/01/2017
(Vom Mitglied beendet)
Stopped prediction by melinda for Dimension Therapeutics Inc
Dimension Therapeutics Inc
Start price
Target price
Perf. (%)
€1.97
13.03.17
13.03.17
€4.51
25.08.17
25.08.17
38.54%
25.08.17
25.08.17


